journal article·2023-12-13Open access

Intracerebral Nanoparticle Transport Facilitated by Alzheimer Pathology and Age

Gregory C. Tracy, Kai-Yu Huang, Yu-Tong Hong, Shengzhe Ding, Hayden A. Noblet, Ki H. Lim, Eung Chang Kim, Hee Jung Chung, Hyunjoon Kong

Nano Letters· Volume 23· Issue 23

Abstract

Nanoparticles have emerged as potential transporters of drugs targeting Alzheimer's disease (AD), but their design should consider the blood-brain barrier (BBB) integrity and neuroinflammation of the AD brain. This study presents that aging is a significant factor for the brain localization and retention of nanoparticles, which we engineered to bind with reactive astrocytes and activated microglia. We assembled 200 nm-diameter particles using a block copolymer of poly(lactic-co-glycolic acid) (PLGA) and CD44-binding hyaluronic acid (HA). The resulting PLGA-b-HA nanoparticles displayed increased binding to CD44-expressing reactive astrocytes and activated microglia. Upon intravascular injection, nanoparticles were localized to the hippocampi of both APP/PS1 AD model mice and their control littermates at 13-16 months of age due to enhanced transvascular transport through the leaky BBB. No particles were found in the hippocampi of young adult mice. These findings demonstrate the brain localization of nanoparticles due to aging-induced BBB breakdown regardless of AD pathology.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Alzheimer's disease research and treatments · Neuroinflammation and Neurodegeneration Mechanisms · Barrier Structure and Function Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Molecular and Integrative Physiology, University of Illinois at Urbana−Champaign, Urbana, Illinois 61801, United States

Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana−Champaign, Urbana, Illinois 61801, United States

Neuroscience Program, University of Illinois at Urbana−Champaign, Urbana, Illinois 61801, United States

Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana−Champaign, Urbana, Illinois 61801, United States

Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana−Champaign, Urbana, Illinois 61801, United States

KU-KIST Graduate School of Converging Science and Technology, Korea University, Seongbuk-gu, Seoul 02841, South Korea

Funding

National Institute of Neurological Disorders and Stroke · National Heart, Lung, and Blood Institute · Alzheimer's Association · Campus Research Board · Chan Zuckerberg Biohub Chicago Acceleration Research Award

References (71)

Show source-provided references
1. 10.1016/S1474-4422(18)30499-X10.1016/S1474-4422(18)30499-X ↗
2. 10.1212/WNL.34.7.93910.1212/WNL.34.7.939 ↗
3. 10.1002/alz.1232810.1002/alz.12328 ↗
4. 10.1016/j.neuron.2017.02.00110.1016/j.neuron.2017.02.001 ↗
5. 10.1002/anie.20220148510.1002/anie.202201485 ↗
6. 10.1038/nrd350510.1038/nrd3505 ↗
7. 10.1001/jamaneurol.2013.584710.1001/jamaneurol.2013.5847 ↗
8. 10.1016/j.jalz.2016.06.00610.1016/j.jalz.2016.06.006 ↗
9. 10.1021/acs.accounts.1c0005510.1021/acs.accounts.1c00055 ↗
10. 10.1186/alzrt26910.1186/alzrt269 ↗
11. 10.1016/j.neuron.2011.01.00210.1016/j.neuron.2011.01.002 ↗
12. 10.1016/j.addr.2004.07.00810.1016/j.addr.2004.07.008 ↗
13. 10.1016/j.pharmthera.2009.03.01710.1016/j.pharmthera.2009.03.017 ↗
14. 10.1517/14712598.8.8.106310.1517/14712598.8.8.1063 ↗
15. 10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
16. 10.1021/acsnano.6b0604010.1021/acsnano.6b06040 ↗
17. 10.1615/CritRevTherDrugCarrierSyst.201501090310.1615/CritRevTherDrugCarrierSyst.2015010903 ↗
18. 10.3390/ijms2308415310.3390/ijms23084153 ↗
19. 10.1016/j.jconrel.2017.12.01510.1016/j.jconrel.2017.12.015 ↗
20. 10.1111/j.1749-6632.2008.03972.x10.1111/j.1749-6632.2008.03972.x ↗
21. 10.1038/nrneurol.2017.18810.1038/nrneurol.2017.188 ↗
22. 10.3233/JAD-2012-12082010.3233/JAD-2012-120820 ↗
23. 10.1016/j.neubiorev.2017.05.00110.1016/j.neubiorev.2017.05.001 ↗
24. 10.3233/JAD-18090510.3233/JAD-180905 ↗
25. 10.1097/WAD.000000000000032810.1097/WAD.0000000000000328 ↗
26. 10.1152/physrev.00050.201710.1152/physrev.00050.2017 ↗
27. 10.1038/s41380-019-0458-510.1038/s41380-019-0458-5 ↗
28. 10.1172/JCI9060310.1172/JCI90603 ↗
29. 10.1146/annurev-pathol-051217-11101810.1146/annurev-pathol-051217-111018 ↗
30. 10.1016/j.jconrel.2014.08.02710.1016/j.jconrel.2014.08.027 ↗
31. 10.1088/0031-9155/59/22/677510.1088/0031-9155/59/22/6775 ↗
32. 10.1016/j.biomaterials.2019.01.03910.1016/j.biomaterials.2019.01.039 ↗
33. 10.3389/fncel.2015.0017510.3389/fncel.2015.00175 ↗
34. 10.1186/s12974-017-0968-510.1186/s12974-017-0968-5 ↗
35. 10.1523/JNEUROSCI.4506-12.201310.1523/JNEUROSCI.4506-12.2013 ↗
36. 10.1002/ana.2010110.1002/ana.20101 ↗
37. 10.1093/brain/awac23610.1093/brain/awac236 ↗
38. 10.1111/micc.1218610.1111/micc.12186 ↗
39. 10.3389/fphar.2019.0100810.3389/fphar.2019.01008 ↗
40. 10.1016/j.neures.2017.11.01210.1016/j.neures.2017.11.012 ↗
41. 10.1007/s12035-015-9428-310.1007/s12035-015-9428-3 ↗
42. 10.1083/jcb.20170906910.1083/jcb.201709069 ↗
43. 10.3390/molecules2717548110.3390/molecules27175481 ↗
44. 10.1016/j.nbd.2004.10.02210.1016/j.nbd.2004.10.022 ↗
45. 10.1016/j.neuint.2012.07.00710.1016/j.neuint.2012.07.007 ↗
46. 10.1523/JNEUROSCI.5289-14.201510.1523/JNEUROSCI.5289-14.2015 ↗
47. 10.1073/pnas.060094810310.1073/pnas.0600948103 ↗
48. Flurkey K. · 2007 · 63710.1016/B978-012369454-6/50074-1 ↗
49. 10.1016/j.neuron.2016.12.01510.1016/j.neuron.2016.12.015 ↗
50. 10.1111/vcp.1231410.1111/vcp.12314 ↗
51. 10.3390/nano1213224810.3390/nano12132248 ↗
52. 10.1016/j.jconrel.2016.12.02410.1016/j.jconrel.2016.12.024 ↗
53. 10.3390/pharmaceutics1304050010.3390/pharmaceutics13040500 ↗
54. 10.1177/088532821142949510.1177/0885328211429495 ↗
55. 10.1096/fasebj.6.7.156359210.1096/fasebj.6.7.1563592 ↗
56. 10.1016/j.addr.2016.02.00810.1016/j.addr.2016.02.008 ↗
57. 10.1188/04.CJON.263-26710.1188/04.CJON.263-267 ↗
58. 10.1159/00034321110.1159/000343211 ↗
59. 10.1007/s11357-020-00211-210.1007/s11357-020-00211-2 ↗
60. 10.1016/j.neuron.2014.12.03210.1016/j.neuron.2014.12.032 ↗
61. 10.1016/j.jalz.2018.06.285710.1016/j.jalz.2018.06.2857 ↗
62. 10.1016/S0021-9258(19)61467-510.1016/S0021-9258(19)61467-5 ↗
63. 10.1038/s41416-022-01999-w10.1038/s41416-022-01999-w ↗
64. 10.1016/j.neuroscience.2018.05.00210.1016/j.neuroscience.2018.05.002 ↗
65. 10.1186/s12979-015-0029-910.1186/s12979-015-0029-9 ↗
66. 10.18632/oncotarget.2094410.18632/oncotarget.20944 ↗
67. 10.1007/s11095-011-0513-710.1007/s11095-011-0513-7 ↗
68. 10.1016/j.biomaterials.2011.03.03110.1016/j.biomaterials.2011.03.031 ↗
69. 10.1126/sciadv.abc703110.1126/sciadv.abc7031 ↗
70. 10.1016/j.ejpb.2014.02.00710.1016/j.ejpb.2014.02.007 ↗
71. 10.1002/jat.324710.1002/jat.3247 ↗